← All organizations
KK Women's and Children's Hospital
Academic/HospitalWebsite ↗
Also known as: CMB, KK Hospital | Consultant at KK Women's and Children's Hospital, Singapore | KK Women's and Children's Hospital | KK Women's and Children's Hospital, BMTCT | KK Women's and Children's Hospital (KKH) | KK Women's and Children's Hospital, Singapore | KK Women's and Children's Hospital, SingHealth | KK Women's & Children's Hospital, SINGAPORE
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2003Last known activity
Aug 1, 2025
Timeline
1850s
- Jun 1, 1858
KK Women's and Children's Hospital— Founded
Drugs by trial phase (49 distinct, 39 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Azoospermia
- Birth Weight
- Brain Diseases
- Brain Ischemia
- Breakthrough Pain
- Carcinoma, Ovarian Epithelial
- Depression
- Depressive Disorder
- Ductus Arteriosus, Patent
- Fallopian Tube Neoplasms
- Hemorrhage
- Hernia
- Hernia, Inguinal
- Hypotension
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infertility
- Ischemia
- Labor Pain
- Myopia
- Nausea
- Neurodevelopmental Disorders
- Oligospermia
- Ovarian Hyperstimulation Syndrome
- Ovarian Neoplasms
- Postoperative Nausea and Vomiting
- Postpartum Hemorrhage
- Pruritus
- Refractive Errors
- Respiratory Insufficiency
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Ewing
- Syndrome
- Vomiting
Recent trials (50)
- NCT07091175CollaboratorPhase 2Aug 1, 2025
- NCT06676748Lead sponsorEarly Phase 1Nov 30, 2024
- NCT06048614Sponsor investigatorN/ASep 30, 2023
- NCT06048614Reponsible party - principal investigatorN/ASep 30, 2023
- NCT06048614Lead sponsorN/ASep 30, 2023
- NCT06236191OfficialN/AJul 24, 2023
- NCT06236191Lead sponsorN/AJul 24, 2023
- NCT06236191Sponsor investigatorN/AJul 24, 2023
- NCT05341817Lead sponsorPhase 4Jun 30, 2022
- NCT05341817Overall official - principal investigatorPhase 4Jun 30, 2022
- NCT05341817Reponsible party - principal investigatorPhase 4Jun 30, 2022
- NCT05329064Lead sponsorPhase 4Mar 24, 2022
- NCT05648019Lead sponsorPhase 2Mar 15, 2022
- NCT05648019Overall official - principal investigatorPhase 2Mar 15, 2022
- NCT05142319CollaboratorPhase 3Oct 12, 2021
Details
- Founded
- Singapore, SG Jun 1, 1858
- Last known activity
- Aug 1, 2025